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Most structural studies on the immunoglobulins 
have been performed on the unique proteins found in 
the serum and urine of patients with myeloma and 
Waldenstrom’s disease because these proteins are usually 
present in large amounts, and are chemically and 
immunologically sufficiently homogeneous to be con- 
sidered monoclonal. However, an antibody activity 
has not been shown for the vast majority of these 
immunoglobulin proteins. In contrast, most antibody 
preparations are present in small amounts and are too 
heterogeneous to allow detailed structural study. To 
establish a correlation between antibody structure and 
specificity, it would be helpful to study a group of 
antibodies which were chemically homogeneous and 
which had similar specificity, in other words, a group 
of monoclonal antibodies. 
The cold agglutinins found in the chronic cold 
agglutinin disease are known to be unusual antibodies. 
They are often present in serum in large amounts, are 
sufficiently homogeneous to appear as single narrow 
bands in the beta-gamma region [ 1,2] on cellulose ace- 
tate electrophoresis [3] , and have almost exclusively 
light chains of the Kappa type [4]. Recent studies 
[5] of the alkaline urea starch gel electrophoresis of a 
series of cold agglutinin light chains showed these to 
be comparable to Bence-Jones light chains in their de- 
gree of homogeneity [6]. This report provides evi- 
dence based on amino acid sequence analysis that these 
agglutinins are monoclonal antibodies. 
The anti-1 cold agglutinin from a patient (Ste) with 
chronic cold agglutinin disease was purified from the 
serum by absorption onto red cell stroma at 0-2OC 
and elution at 37OC, followed by Sephadex G-200 Gel 
filtration as described elsewhere [5]. The preparation 
North-Holland Publishing Company - Amsterdam 
was shown to be electrophoretically homogeneous on 
celhrlose acetate [3] and to react only with anti-Mu 
and anti-Kappa type sera by Ouchterlony [7] and im- 
munoelectrophoretic [g] analysis. The purified cold 
agglutinin was reduced with 0.005 M dithiothreitol 
(Cleland’s reagent), and alkylated with a 1% excess 
of iodoacetamide by the methods of Miller and Metz- 
ger [9]. The heavy (Mu) and light (Kappa) chains 
were separated by Sephadex G-100 gel filtration (1 N 
acetic acid) by the method of Fleischman et al. [lo] . 
Of the recovered protein, 75% was heavy chain and 
25% was light chain. Alkaline urea starch gel electro- 
phoresis [6] of the cold agglutinin Kappa chain show- 
ed two strong and two weak bands (fig. 1). 
The N-terminal sequence was determined by the 
phenylisothiocyanate technique [ 111. Ten mg of 
lyophilized Kappa chain were subjected to 22 cycles 
in the protein sequenator [ 121 and the phenylthio- 
dantoin derivatives were identified by thin layer 
chromatography [ 121 except for the derivative of ar- 
ginine, where a Sakaguchi reaction on paper was used. 
Only one amino acid was observed in each position. 
It has recently been shown by Niall and Edman 
[ 131 that Kappa-chains fall into either of two major 
subclasses depending on the sequence at the N-termi- 
nus. Sequences of the two prototypes Kappasmi and 
KappaT, * are shown in table 1. Very similar conclu- 
sions have been reached independently by Smithies 
* In accordance with the suggestions of the World Health Or- 
ganisation [ 141 NiaU and Edman [ 131 provisionally desig- 
nated the new subclasses by abbreviations of the patients’ 
names. These designations will be retained until agreement 
is reached on the kind, number and designations of the 
subclasses. 
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Fig. 1. Alkaline urea starch gel electrophoresis of normal light chains 
(left) and the light chains of cold agglutinin Ste (right). Anode to the 
bottom. 
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N-terminal sequences of a cold agglutinin Kappa chain and of the two major subclasses of Kappa&aim. 
Chain 
KappaSfe 
1 
Amino acid sequence 
10 20 
Glu-Ile-Val-Leu-Thr-Gln-Ser-ProGly-Thr-Leu-Ser-Leu-Ser-Pro-Gly~lu-Arg-A~-~a-Leu-Ser- 
KaPPas,i * Glu-Ile-Val-Leu-Thr-Gln-Ser-Pro-Ala-Thr-~u-Ser-Leu-Ser-Pr~Gly-Glu-Arg-~a-~r-Leu-Ser- 
KaPPay,, * Asp-Ile-GLn-Met-Thr~ln-Ser-Pro-Ser-Ser-Leu-Ser-~a-Ser-V~-Gly-Asp-ArgV~-~r-Be-~r- 
* The sequence of the subclasses KappaS,i and Kappay,, is taken from the work of Niall and Edman [ 131. 
[15]. Milstein [ 161 later presented evidence for a third 
subclass. The latter is obviously a minor group, since it 
is not observed in the sequence analysis of Kappa- 
chains from pooled IgG [13] **. The cold agglutinin 
Kappa chain clearly falls into subclass KappaS,i, from 
which it differs only in positions 9 and 20. The replace- 
ment of alanine for glycine in position 9 is frequently 
observed. However, the replacement of threonine for 
alanine in position 20 is exceptional, since this position 
is common to both subclasses, and has not been obser- 
ved to vary before. This is convincing evidence (a) that 
the peptide chain has a unique amino acid sequence, and 
(b) that the cold agglutinin preparation itself was not de- 
tectably contaminated by the normal immunoglobulins. 
The evidence presented here gives strong support to 
the earlier assumption that the antibodies found in 
chronic cold agglutinin disease are monoclonal in origin. 
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* It seems likely that, as more sequence material is collected, 
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published). 
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